Characteristics of LKDS and PBSS of KOA Based on the Enhancement of Inflammatory Response by TGF-β/Smad Pathway Inhibited
Clinical trial NCT05218122 · UNKNOWN
Trial details
- NCT number
- NCT05218122
- Sponsor
- Dongzhimen Hospital, Beijing
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-24
- Primary completion
- 2024-12-31
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.